Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Bank Saint Petersburg approved the redemption of shares

4/25/24 BSPB

Shareholders of Bank St. Petersburg approved dividends for 2023

4/25/24 BSPB

RusHydro opened 300 charging stations for electric cars

4/25/24 HYDR

One of the largest RC Pyatyorochka opened in Samara region

4/25/24 X5

EL5-Energo's output in Q1 increased by 19%

4/25/24 ELFV

RosDorBank to conduct additional share issue

4/25/24 RDRB

Saratov Refinery reported for 2023 by IFRS

4/25/24 KRKN

Novatek reported for 3 months of 2023 by RAS

4/25/24 NVTK

Moscow Exchange shareholders failed to approve dividends

4/25/24 MOEX

Trust's stake in UWC acquired by UMMC shareholders

4/25/24 UWGN